Latest biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

IBEC engages in two public-private partnerships for biomedical breakthroughs

by IBEC - Institut de Bioenginyeria de Catalunya

5 months ago
IBEC, Vitala Technologies

Initiatives seek to advance remote health monitoring, create an oral drug for Inflammatory Bowel Disease, and enhance 13C magnetic resonance imaging for therapeutic research. Leveraging cutting-edge t...

Computational screening combined with organoid modeling to identify cancer-driving mutations

by VHIO

5 months ago
drivers, computacional screening, oncogenesis, FGF3

It has been validated a new methodology to identify cancer-inducing genetic variations, known as drivers, through the analysis of gene copy increase in preclinical organoid models.

Immunotherapy added to first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

by VHIO

5 months ago
atezolizumab, metastasic cervical cancer, BEATcc study

Result show that adding immune checkpoint inhibitor atezolizumab to standard of care with bevacizumab and chemotherapy significantly improves progression-free survival and overall survival in patients...

ibs.GRANADA researchers obtain funding for a European project to improve maternal and child health during pregnancy

by Instituto de Investigación Biosanitaria - Ibs Granada

5 months ago
Maternal perinatal stress, TREASURE project

The ibs.GRANADA is pleased to announce the approval of an ambitious European project funded with more than 600,000 euros by the European Union to improve the health of children and reduce the economic...

Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer

by IRB Barcelona - Instituto de Investigación Biomédica

5 months ago
Transcription factors, biomolecular condensates, Nuage Therapeutics, androgen

An international team of researchers from the Institute for Research in Biomedicine (IRB Barcelona), the Max Planck Institute for Molecular Genetics (MPIMG), BC Cancer (University of British Columbia)...

New research to develop treatment for ultrarare disease caused by ADSL gene mutation

by Universitat Autònoma de Barcelona (UAB)

5 months ago
adenylsuccinate lyase deficiency (ADSL)

The UAB has launched a new campaign to raise funds to study a gene therapy for adenylsuccinate lyase deficiency (ADSL), a rare genetic disease suffered by about 80 children in the world, including two...

Los alimentos ultraprocesados se asocian a una disminución de la función renal

by Universitat Rovira i Virgili

5 months ago
función renal, alimentos ultraprocesados

Un estudio liderado por un grupo de investigación de la URV-IISPV-CIBEROBN detecta esta relación en personas de edad avanzada con riesgo cardiovascular

The time we eat does matter. The researcher who discovered the first biological clock gene in mammals relates biorhythms to longevity

by CNIO - Centro Nacional de Investigaciones Oncológicas

5 months ago
‘CLOCK’ gene, circadian rhythm

Genes give instructions for the functioning of the body. We now know that each of those instructions is read by cells at a certain time of day, to adapt to the Earth’s light/dark cycle.

Researchers from CIC bioGUNE develop a strategy capable of identifying the cellular components on which the E3 ubiquitin ligase enzymes act

by CIC bioGUNE

5 months ago
E3 ubiquitin ligase enzymes, Targeted Protein Degradation (TPD)

It has beed used innovative strategies to redirect cellular degradation and thus eliminate proteins that cause various diseases.

ORYZON awarded with a grant for ORY-4001 from the ALS Association in the U.S

by Oryzon Genomics

5 months ago
ORY-4001, amyotrophic lateral sclerosis (ALS), HDAC6, ALS Association, Oryzon

The Association has awarded Oryzon a 498,690 USD grant through its Lawrence and Isabel Barnett Drug Development Program to support the regulatory preclinical development of ORY-4001, a highly selectiv...

ALLOX, a new Centre for Genomic Regulation spin-off, is launched with the support of Asabys

by Asabys Partners

5 months ago
ALLOX, Sabadell Asabys II, Asabys Partners, CRG, allosteric sites

ALLOX, a techbio company developing a proprietary technology to design new drugs targeting allosteric sites within oncology and other diseases, announces its incorporation today, as well as the succes...

Diseño de un hidrogel inyectable para un tratamiento menos tóxico del cáncer de mama

by Instituto de Investigación Biomédica de Salamanca - IBSAL

5 months ago
cánceres de mama HER 2+, hidrogel

La profesora Eva Martín del Valle, investigadora del Instituto de Investigación Biomédica de Salamanca (IBSAL) y catedrática de Ingeniería Química de la Universidad de Salamanca (USAL), ha lid...